header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

Short Term Results of Primary THA Using RevelationV2: A Lateral Flare Femoral Component

The International Society for Technology in Arthroplasty (ISTA)



Abstract

Dislocation after total hip arthroplasty (THA) is one of the most serious complications. We recently modified the design of Lateral Flare femoral component (RevelationV2) with six degrees lower anteversion to reproduce the normal hip condition in Japanese. In addition, we added 10-degree slope on the posterior neck to prevent dislocation especially aimed to high anteversion cases. The purpose of this study is to verify the clinical outcome after this design modification.

Hospital records and database were retrospectively reviewed. We investigated 46 consecutive hips in 43 patients who underwent primary total hip arthroplasty using RevelationV2 from September 2007 to August 2009. All patients implicated preoperative planning using CAT scan with their informed consents.

The mean age and BMI at surgery were 63 years old and 23.1. Preoperative diagnosis was osteoarthritis (40/46: 87%), rheumatoid arthritis (2/46: 4%) or avascular necrosis of femoral head (4/46: 9%). There were 41 hips (89.2%) of Crowe I, 3(6.5%) of Crowe II and 2(4.3%) of Crowe III. Preoperative femoral neck anteversion averaged 28 degrees, whereas postoperative combined anteversion (the sum of femoral neck anteversion and anterior cup inclination) averaged 46 degrees. During follow up, 5 complications, in details, 3 mild peroneal nerve palsy, 1 pulmonary embolism and 1 dislocation following deep infection were reported. In conclusion, although no ordinal dislocation was found in this series, longer observation will need to judge appropriateness of this new component.


Email: